Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Johnson

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
Experimental and Clinical Psychopharmacology|July 15, 2021
The discounting of death: Probability discounting of heroin use by fatal overdose likelihood and drug puritySean B Dolan, Matthew W Johnson, Kelly E Dunn, et al.
Alcoholism, Clinical and Experimental Research|May 1, 2016
Alcohol Increases Delay and Probability Discounting of Condom-Protected Sex: A Novel Vector for Alcohol-Related HIV TransmissionPatrick S Johnson, Mary M Sweeney, Evan S Herrmann, et al.
Plos One|May 29, 2015
Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controlsMatthew W Johnson, Patrick S Johnson, Evan S Herrmann, et al.
Journal of Psychiatric Research|June 4, 2025
Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience QuestionnaireKristoffer A A Andersen, Bjørn Holmøy, Tor-Morten Kvam, et al.
Journal of Psychopharmacology (Oxford, England)|September 3, 2019
Potential for limited reinforcing and abuse-related subjective effects of intranasal oxytocinSean B Dolan, Meredith S Berry, Patrick S Johnson, et al.
Journal of Psychopharmacology (Oxford, England)|September 13, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionMatthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, et al.
Pharmacology & Therapeutics|December 7, 2018
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network functionMatthew W Johnson, Peter S Hendricks, Frederick S Barrett, et al.
Drug and Alcohol Dependence|July 31, 2009
Response disinhibition evoked by the administration of nicotine and nicotine-associated contextual cuesAri P Kirshenbaum, Matthew W Johnson, Sarah L Schwarz, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|October 23, 2008
Celiac disease in the elderlyMatthew W Johnson, H Julia Ellis, Max A Asante, et al.
Psychopharmacology|March 3, 2023
The Blinded-Dose Purchase Task: assessing hypothetical demand based on cocaine, methamphetamine, and alcohol administrationMeredith S Berry, Gideon P Naudé, Patrick S Johnson, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Experimental and Clinical Psychopharmacology|July 15, 2021
The discounting of death: Probability discounting of heroin use by fatal overdose likelihood and drug puritySean B Dolan, Matthew W Johnson, Kelly E Dunn, et al.
Alcoholism, Clinical and Experimental Research|May 1, 2016
Alcohol Increases Delay and Probability Discounting of Condom-Protected Sex: A Novel Vector for Alcohol-Related HIV TransmissionPatrick S Johnson, Mary M Sweeney, Evan S Herrmann, et al.
Plos One|May 29, 2015
Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controlsMatthew W Johnson, Patrick S Johnson, Evan S Herrmann, et al.
Journal of Psychiatric Research|June 4, 2025
Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience QuestionnaireKristoffer A A Andersen, Bjørn Holmøy, Tor-Morten Kvam, et al.
Journal of Psychopharmacology (Oxford, England)|September 3, 2019
Potential for limited reinforcing and abuse-related subjective effects of intranasal oxytocinSean B Dolan, Meredith S Berry, Patrick S Johnson, et al.
Journal of Psychopharmacology (Oxford, England)|September 13, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionMatthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, et al.
Pharmacology & Therapeutics|December 7, 2018
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network functionMatthew W Johnson, Peter S Hendricks, Frederick S Barrett, et al.
Drug and Alcohol Dependence|July 31, 2009
Response disinhibition evoked by the administration of nicotine and nicotine-associated contextual cuesAri P Kirshenbaum, Matthew W Johnson, Sarah L Schwarz, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|October 23, 2008
Celiac disease in the elderlyMatthew W Johnson, H Julia Ellis, Max A Asante, et al.
Psychopharmacology|March 3, 2023
The Blinded-Dose Purchase Task: assessing hypothetical demand based on cocaine, methamphetamine, and alcohol administrationMeredith S Berry, Gideon P Naudé, Patrick S Johnson, et al.
Pageof 18